The Discounted Cash Flow (DCF) valuation of Ayala Pharmaceuticals Inc (AYLA) is (359.58) USD. With the latest stock price at 0.50 USD, the upside of Ayala Pharmaceuticals Inc based on DCF is -71502.1%.
Based on the latest price of 0.50 USD and our DCF valuation, Ayala Pharmaceuticals Inc (AYLA) is a sell. selling AYLA stocks now will result in a potential gain of 71502.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 7.7% | 6.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (2,724.19) - (196.47) | (359.58) |
| Upside | -541041.4% - -39113.1% | -71502.1% |